Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Long-Term Memory Decline clinical trials

1 of 2 indexed Long-Term Memory Decline trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Long-Term Memory Decline: 2 US clinical trials tracked, 1 recruiting.

Long-Term Memory Decline is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of California, San Francisco, running 2 of these trials.

Enrollment posture brief

Registry condition long-term-memory-decline

OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Long-Term Memory Decline (th…50%
Open-enrollment share among volume-matched conditions near Long-Term Memory Decline

Long-Term Memory Decline lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Long-Term Memory Decline on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Long-Term Memory Decline is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Long-Term Memory Decline records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Tablet Device
1 trials
Coherence Device
1 trials
Placebo Games Device
1 trials
LabyrinthVR Device
1 trials
Labyrinth VR wireless Behavioral
1 trials
Labyrinth Tablet software Behavioral
1 trials
Placebo Games software Behavioral
1 trials
LabyrinthVR software Behavioral
1 trials

US sites by state

Facility locations filed on Long-Term Memory Decline trials. A trial with sites in several states counts in each.

California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Long-Term Memory Decline page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Long-Term Memory Decline condition card totals 2 registered trials; most-linked intervention Tablet; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.